LLY
Eli Lilly and Company · Healthcare · Drug Manufacturers - General
$1,142.85
-0.61% today · -3.43% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- LLY −0.61% on the last session vs SPY +0.74%: −1.3 pts of stock-specific move.
- 1 analyst action in the past 10 days (1 positive, 0 negative); latest: JP Morgan maintained Overweight, raised target $1,400 → $1,500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 29
Before the open · in 25 days
EPS estimate
$9.96
$9.23 to $11.31 · 17 analysts
Revenue estimate
$22.4B
$21.4B to $24.0B
Track record
6/8 beats
last 8 reports · moved ±8.0% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 BMO | 2Q2026 | $6.58 | $8.38 | +$1.80 (+27.3%) beat | $23.0B | +4.9% +5.1 vs SPY | +5.2% | +8.9% |
| Apr 30, 2026 BMO | 1Q2026 | $6.79 | $8.55 | +$1.76 (+25.9%) beat | $19.8B | +9.8% +8.8 vs SPY | +5.6% | +16.0% |
| Feb 4, 2026 BMO | 4Q2025 | $6.91 | $7.54 | +$0.63 (+9.1%) beat | $19.3B | +10.3% +10.8 vs SPY | +7.1% | +2.1% |
| Oct 30, 2025 BMO | 3Q2025 | $5.89 | $7.02 | +$1.13 (+19.2%) beat | $17.6B | +3.8% +4.9 vs SPY | +3.0% | +13.8% |
| Aug 7, 2025 BMO | $5.59 | $6.31 | +$0.72 (+12.9%) beat | — | -14.1% -14.1 vs SPY | -9.5% | -11.5% | |
| May 1, 2025 BMO | $3.46 | $3.34 | −$0.12 (−3.5%) miss | — | -11.7% -12.4 vs SPY | -6.1% | -13.6% | |
| Feb 6, 2025 BMO | $5.07 | $5.32 | +$0.25 (+4.9%) beat | — | +3.4% +3.0 vs SPY | -0.3% | +3.7% | |
| Oct 30, 2024 BMO | $1.47 | $1.18 | −$0.29 (−19.7%) miss | — | -6.3% -6.0 vs SPY | -11.6% | -10.8% | |
| Aug 8, 2024 BMO | $2.77 | $3.92 | +$1.15 (+41.5%) beat | — | +9.5% +7.2 vs SPY | +13.3% | +20.7% | |
| Apr 30, 2024 BMO | $2.49 | $2.58 | +$0.09 (+3.6%) beat | — | +6.0% +7.5 vs SPY | +5.1% | +4.0% | |
| Feb 6, 2024 BMO | $2.37 | $2.49 | +$0.12 (+5.1%) beat | — | -0.2% -0.5 vs SPY | +5.1% | +4.4% | |
| Nov 2, 2023 BMO | −$0.12 | $0.10 | +$0.22 (>+100%) beat | — | +4.7% +2.7 vs SPY | +4.3% | +11.7% | |
| Aug 8, 2023 BMO | $1.99 | $2.11 | +$0.12 (+6.0%) beat | — | +14.9% +15.3 vs SPY | +11.4% | +18.7% | |
| Apr 27, 2023 BMO | $1.73 | $1.62 | −$0.11 (−6.4%) miss | — | +3.7% +1.8 vs SPY | +4.0% | +14.6% | |
| Feb 2, 2023 BMO | $1.83 | $2.09 | +$0.26 (+14.2%) beat | — | -3.5% -4.9 vs SPY | -2.5% | -0.5% | |
| Nov 1, 2022 BMO | $1.94 | $1.98 | +$0.04 (+2.1%) beat | — | -2.6% -2.2 vs SPY | -4.5% | +0.8% | |
| Aug 4, 2022 BMO | $1.70 | $1.25 | −$0.45 (−26.5%) miss | — | -2.6% -2.5 vs SPY | -1.2% | -2.9% | |
| Apr 28, 2022 BMO | $2.29 | $2.62 | +$0.33 (+14.4%) beat | — | +4.3% +1.7 vs SPY | +3.8% | +3.4% | |
| Feb 3, 2022 BMO | $2.51 | $2.49 | −$0.02 (−0.8%) miss | — | -2.4% -0.1 vs SPY | -1.3% | -3.0% | |
| Oct 26, 2021 BMO | $1.96 | $1.94 | −$0.02 (−1.0%) miss | — | +1.4% +1.3 vs SPY | -0.2% | +1.7% | |
| Aug 3, 2021 BMO | $1.89 | $1.87 | −$0.02 (−1.1%) miss | — | — | — | — | |
| Apr 27, 2021 BMO | $2.10 | $1.87 | −$0.23 (−11.0%) miss | — | — | — | — | |
| Jan 29, 2021 BMO | $2.39 | $2.75 | +$0.36 (+15.1%) beat | — | — | — | — | |
| Oct 27, 2020 BMO | $1.71 | $1.54 | −$0.17 (−9.9%) miss | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $9.96 (17) | $9.23 – $11.31 | +42% | +5.7% | ▲2 ▼0 | $22.4B | +27% |
| Next quarter · Dec 31, 2026 | $10.06 (17) | $9.15 – $11.64 | +33% | +1.5% | ▲3 ▼0 | $23.3B | +21% |
| Current year · Dec 31, 2026 | $36.95 (27) | $35.53 – $40.77 | +53% | +2.0% | ▲4 ▼2 | $88.5B | +36% |
| Next year · Dec 31, 2027 | $47.59 (27) | $40.73 – $54.94 | +29% | +7.0% | ▲4 ▼2 | $102.1B | +15% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.